Why is Laurus Labs Ltd ?
- The company has declared positive results for the last 7 consecutive quarters
- OPERATING PROFIT TO INTEREST(Q) Highest at 15.12 times
- OPERATING CF(Y) Highest at Rs 1,623.50 Cr
- ROCE(HY) Highest at 17.30%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 1.95% over the previous quarter.
- Along with generating 115.16% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
How much should you buy?
- Overall Portfolio exposure to Laurus Labs should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Laurus Labs for you?
Medium Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at 15.12 times
Highest at Rs 1,623.50 Cr
Highest at 17.30%
Highest at Rs 2,026.31 cr
Highest at Rs 638.27 cr.
Highest at 31.50%
Highest at Rs 472.18 cr.
Highest at Rs 367.60 cr.
Highest at Rs 6.80
Lowest at 12.15%
Here's what is working for Laurus Labs
Operating Profit to Interest
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
Net Sales (Rs Cr)
Operating Profit (Rs Cr)
Operating Profit to Sales
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
Operating Cash Flows (Rs Cr)
Net Sales (Rs Cr)
EPS (Rs)
Here's what is not working for Laurus Labs
DPR (%)






